The MRNA Therapeutics Contract Development & Manufacturing Market was valued at USD 3.12 billion in 2023 and is projected to reach USD 8.09 billion by 2032, expanding at a CAGR of 11.18% during the forecast period 2024-2032. The market growth is primarily driven by the rising adoption of mRNA-based therapeutics, increasing outsourcing by...